Exclusive Interview: 3 E Network CEO Dr. Yang Tingjun on Cryptocurrency and the Future of Technology

(NASDAQ:MASK), Hong Kong, China, Aug. 07, 2025 (GLOBE NEWSWIRE) — 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3e Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider, is pleased to announce the release of a compelling interview featuring Dr. Yang Tingjun, Chief Executive Officer of 3E Network. Amid ongoing volatility […]

Parker Reports Fiscal 2025 Fourth Quarter and Full Year Results

(NYSE:PH), CLEVELAND, Aug. 07, 2025 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter and fiscal year ended June 30, 2025, that included the following highlights (compared with the prior year period): Fiscal 2025 Fourth Quarter Highlights: Sales were a record $5.2

Bombardier to Launch Major U.S. Services Expansion Initiative Across Multiple States

(TSX:BBD-A),(TSX:BBD-B),(OTC US:BDRBF),(Other OTC:BDRBF), Bombardier's U.S. Services network is set to grow through a multi-phase, multi-site expansion initiative focusing on existing geographies where the company operates, in addition to new ones The expansion initiative is expected to generate a need for highly skilled labour, with Bombardier anticipating new jobs created for each project The planned phased

Lockheed Martin Corporation (LMT) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 26, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 7, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=160180&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Bread Financial Announces Early Tender Results of its Previously Announced Cash Tender Offers and Extends Total Consideration Through the Expiration Date

(NYSE:BFH), COLUMBUS, Ohio, Aug. 07, 2025 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) announced that as of 5:00 p.m., New York City time, on August 6, 2025 (the “Early Participation Date”), pursuant to and in accordance with its previously announced cash tender offers (the “Tender Offers”) described in

Genie Energy Announces Second Quarter 2025 Results

(NYSE:GNE),(NYSE:GNEPRA), Newark, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) — Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the second quarter of 2025. Michael Stein, Chief Executive Officer of Genie Energy, commented: “Our second quarter yielded mixed results with solid operational progress and double-digit topline growth,

TEGNA Inc. Reports Second Quarter 2025 Results and Provides Third Quarter Guidance

(NYSE:TGNA), Achieves Key Guidance Metrics Reaffirms 2024/2025 Two-Year Adjusted Free Cash Flow guidance TYSONS, Va., Aug. 07, 2025 (GLOBE NEWSWIRE) — TEGNA Inc. (NYSE: TGNA) today announced financial results for the second quarter ended June 30, 2025. “We delivered on our financial commitments this quarter while making important progress on the strategic initiatives that will

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

(NASDAQ:ACHV), SEATTLE and VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced its financial results for second quarter 2025. “This quarter represents a significant

Kelly Reports Second-Quarter 2025 Earnings

(NASDAQ:KELYA),(NASDAQ:KELYB), TROY, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the second quarter of 2025. Q2 revenue of $1.1 billion, up 4.2% year-over-year reflecting previously disclosed acquisitions, and down 3.3% on an organic basis Q2 operating earnings of $22.2 million; $24.6 million

Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update

(NASDAQ:CABA), – Registrational cohort enrollment in RESET-Myositis(TM) trial on track to start in 2H25 with anticipated 2027 BLA submission for rese-cel in myositis – – Five disease-specific cohorts fully enrolled in the RESET(TM) clinical development program from over 70 clinical sites as of July 31, 2025, with expansion phase enrollment continuing – – FDA meetings

Scroll to Top